Back
PTC Therapeutics Stock Price Chart
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PTCT
PTC Therapeutics
Last Price:
50.29
Seasonality Move:
17.12%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
PTC Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.81 | Buy |
| 20-day SMA: | 43.67 | Buy |
| 50-day SMA: | 40.62 | Buy |
| 200-day SMA: | 34.19 | Buy |
| 8-day EMA: | 46.55 | Buy |
| 20-day EMA: | 44.07 | Buy |
| 50-day EMA: | 41.1 | Buy |
| 200-day EMA: | 35.83 | Buy |
PTC Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.11 | Buy |
| Relative Strength Index (14 RSI): | 66.75 | Buy |
| Chaikin Money Flow: | -849912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.04 - 46.16) | Buy |
| Bollinger Bands (100): | (32.47 - 41.53) | Buy |
PTC Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 50.29 while PTCT 8-day simple moving average is 45.81, which is a Buy signal.
- The stock price of PTCT is 50.29 while PTC Therapeutics 20-day SMA is 43.67, which makes it a Buy.
- PTC Therapeutics 50-day simple moving average is 40.62 while PTCT share price is 50.29, making it a Buy technically.
- PTCT stock price is 50.29 and PTC Therapeutics 200-day simple moving average is 34.19, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Buy
51
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a Buy
The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
PTC Therapeutics Stock Info
Market Cap:
3.88B
Price in USD:
50.29
Share Volume:
1.45M
PTC Therapeutics 52-Week Range
52-Week High:
54.16
52-Week Low:
23.58
Buy
51
PTC Therapeutics (PTCT)
is a Buy
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?
The PTC Therapeutics stock price is 50.29 USD today. -
Will PTCT stock go up or go down?
PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is PTC Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is not overvalued.
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 50.29 while PTCT 8-day exponential moving average is 46.55, which is a Buy signal.
- The stock price of PTCT is 50.29 while PTC Therapeutics 20-day EMA is 44.07, which makes it a Buy.
- PTC Therapeutics 50-day exponential moving average is 41.10 while PTCT share price is 50.29, making it a Buy technically.
- PTCT stock price is 50.29 and PTC Therapeutics 200-day simple moving average is 35.83, creating a Buy signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
- PTCT Moving Average Covergence Divergence (MACD) indicator is 2.11, suggesting PTC Therapeutics is a Buy
- PTC Therapeutics Relative Strength Index (RSI) is 66.75, which suggest PTC Therapeutics is overbought
- The Bollinger Bands (25) for PTC Therapeutics is (40.04 - 46.16), which suggest PTC Therapeutics is a Buy
- The Bollinger Bands (100) for PTC Therapeutics is (32.47 - 41.53), which suggest PTC Therapeutics is a Buy
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.